DIALYSIS · CCN 332856

USRC ROME DIALYSIS

ROME, NY 13441

DialysisProfitUS Renal Care, Inc.
$3.1M
TOTAL REVENUE
-3.5%
OPERATING MARGIN
2 / 5
STAR RATING
13
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.1M
Total costs
$3.2M
Operating income (rev − costs)
−$110K
Operating margin
-3.5%
Total charges
$3.1M
Total treatments
7,555
Dialysis stations
16

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
10055—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.516—
Fistula Rate
DFC_FISTULA_RATE
44.357—
Five Star Rating
DFC_FIVE_STAR
2——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
147.239—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
056—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.57——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
3057—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
739—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
13.541—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
49.928—
Standardized ED Visits Ratio
DFC_SEDR
0.7722—